Cargando…

Precision medicine applications in prostate cancer

Aided by developments in diagnostics and therapeutics, healthcare is increasingly moving toward precision medicine, in which treatment is customized to each individual. We discuss the relevance of precision medicine in prostate cancer, including gene targets, therapeutics and resistance mechanisms....

Descripción completa

Detalles Bibliográficos
Autores principales:	McCrea, Edel M., Lee, Daniel K., Sissung, Tristan M., Figg, William D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024288/ https://www.ncbi.nlm.nih.gov/pubmed/29977347 http://dx.doi.org/10.1177/1758835918776920

Ejemplares similares

Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
por: Sissung, Tristan M., et al.
Publicado: (2022)

Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p
por: Barbier, Roberto H., et al.
Publicado: (2021)

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients
por: Pastina, Ilaria, et al.
Publicado: (2010)

Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression
por: Pressler, Heather, et al.
Publicado: (2011)

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer
por: English, Bevin C, et al.
Publicado: (2010)

Single whole genome sequencing analysis blazes the trail for precision medicine
por: Napoli, Giulia C., et al.
Publicado: (2022)

Functional Drug Screening in the Era of Precision Medicine
por: Napoli, Giulia C., et al.
Publicado: (2022)

Bipolar disorder and neurophysiologic mechanisms
por: McCrea, Simon M
Publicado: (2008)

Intuition, insight, and the right hemisphere: Emergence of higher sociocognitive functions
por: McCrea, Simon M
Publicado: (2010)

Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine
por: Suh, Yoon Seok, et al.
Publicado: (2017)

Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine
por: Meehan, James, et al.
Publicado: (2021)

Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer
por: Sissung, Tristan M., et al.
Publicado: (2019)

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
por: Smith, Bethany, et al.
Publicado: (2017)

Molecular Characterization of Prostate Cancers in the Precision Medicine Era
por: Giunta, Emilio Francesco, et al.
Publicado: (2021)

The Value of Phenotypic Precision Medicine in Prostate Cancer
por: Hawkey, Nathan M, et al.
Publicado: (2022)

The Study of Influenza
por: McCrea, John F.
Publicado: (1962)

The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine
por: Lewis, Deyana D., et al.
Publicado: (2020)

Applying precision medicine to the active surveillance of prostate cancer
por: Reichard, Chad A., et al.
Publicado: (2015)

The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)

Física relativista
por: McCrea, William Hunter
Publicado: (1965)

Geometría analítica de tres dimensiones
por: McCrea, William Hunter

Cosmology
por: McCrea, William Hunter
Publicado: (1969)

Relativity physics
por: McCrea, William Hunter
Publicado: (1947)

Relativity physics
por: McCrea, William Hunter
Publicado: (1949)

Relativity physics
por: McCrea, William Hunter
Publicado: (1954)

Analytical geometry of three dimensions
por: McCrea, William Hunter
Publicado: (1947)

Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer
por: Adamaki, Maria, et al.
Publicado: (2021)

Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
por: Dulaney, Caleb R., et al.
Publicado: (2016)

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management
por: Doan, David K., et al.
Publicado: (2021)

Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndrome
por: Valle, Luca, et al.
Publicado: (2022)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
por: Lochrin, Sarah E., et al.
Publicado: (2021)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures
por: Huang, Xuan, et al.
Publicado: (2012)

Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?
por: Gao, Rui, et al.
Publicado: (2013)

A review and empirical study of the composite scales of the Das–Naglieri cognitive assessment system
por: McCrea, Simon M
Publicado: (2009)

A novel application of mark-recapture to examine behaviour associated with the online trade in elephant ivory
por: Yeo, Lydia M., et al.
Publicado: (2017)

Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018)

Definition and application of precision medicine
por: Wang, Zheng-Guo, et al.
Publicado: (2016)

On Strapping the Chest in Phthisis
por: McCrea, John
Publicado: (1874)

Biomarker Application for Precision Medicine in Stroke
por: Simpkins, Alexis N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4vfgjt04crqhqomjad9c3s4p93